We have long been of the view that allowing the degree of provider, and in particular hospital, consolidation that has occurred in the United States would be a significant cause of health care spending growth, a view which has been supported by ongoing research. The latest evidence comes from a Center for Studying Health System Change Report. (CSHSC Report) Examining 13 metropolitan areas largely in the midwest, the report finds that commercial health plans usually pay much higher prices than either Medicare or Medicaid and that hospital prices vary widely within and between markets. Using data from autoworker plans on the total (payer and patient) amounts actually paid to hospitals for services, as well as for other categories of service. On average, the highest-priced hospital received 60% more for the same inpatient service than did the lowest-price hospital in the same market. For hospital outpatient care, the highest-price hospital was paid twice as much as the lowest-price one. In every market the average payments by commercial insurers to hospitals for inpatient services were well-above Medicare rates. Prices for primary care services were closer to Medicare reimbursements and less variable but specialty physician services had both more variability and tended to be higher about the Medicare payments. These differences in price are not likely explained by labor costs, which tend to be the roughly the same across facilities and markets, differences in service complexity or differences in benefits. The authors conclude that negotiating leverage is the primary cause of both the variation and the higher than Medicare prices. Primary care tends to be the most competitive, with fewer competing specialists and many hospital markets are very concentrated. Health plan concentration levels may also affect provider prices. You would think that dominant health plans could drive better prices with hospitals but in many cases it seems that such plans decide to “share the wealth”; i.e. both providers and the health plan just charge higher prices which flow through to the ultimate payers–employers and patients. Employers, consumers and health plans that wish to do something about high provider prices need to aggressively move volume to lower-priced alternatives, regardless of reputation and size.
✅ Subscribe via Email
About this Blog
Healthy Skeptic Podcast
Research
MedPAC 2019 Report to Congress
June 18, 2019
Headlines
Tags
Access
ACO
Care Management
Chronic Disease
Comparative Effectiveness
Consumer Directed Health
Consumers
Devices
Disease Management
Drugs
EHRs
Elder Care
End-of-Life Care
FDA
Financings
Genomics
Government
Health Care Costs
Health Care Quality
Health Care Reform
Health Insurance
Health Insurance Exchange
HIT
HomeCare
Hospital
Hospital Readmissions
Legislation
M&A
Malpractice
Meaningful Use
Medicaid
Medical Care
Medicare
Medicare Advantage
Mobile
Pay For Performance
Pharmaceutical
Physicians
Providers
Regulation
Repealing Reform
Telehealth
Telemedicine
Wellness and Prevention
Workplace
Related Posts
Commentary
March 31, 2023
Electric Vehicles Suck
Electric cars are more expensive to buy and operate than gas ones, and worse for…
Commentary
March 31, 2023
Coronamonomania Lives Forever, Part 202
Such a depressing world and I am not sure these research summaries are particularly elevating.
Commentary
March 31, 2023
And Then There is This…
Some supposed conservatives just spout conspiratorial nonsense that ensures that we lose, which is one…